NDRA ENDRA Life Sciences
- 0.4200
- +0.0105+2.56%
- 0.4230
- +0.0030+0.71%
ENDRA Life Sciences News
4: Statement of changes in beneficial ownership of securities-10% Owner UBS Group AG
3: Initial statement of beneficial ownership of securities-10% Owner UBS Group AG
3: Initial statement of beneficial ownership of securities-Officer Jacroux Richard
SC 13G: Statement of acquisition of beneficial ownership by individuals-S.H.N. Financial Investments Ltd.(9.99%)
SC 13G: Statement of acquisition of beneficial ownership by individuals-L1 Capital Global Opportunities Master Fund, Ltd.(9.99%)
ENDRA Life Sciences | 4: Statement of changes in beneficial ownership of securities-Director Basenese Lou
ENDRA Life Sciences | 4: Statement of changes in beneficial ownership of securities-Director Harsh Michael
ENDRA Life Sciences | 4: Statement of changes in beneficial ownership of securities-Director DIGIANDOMENICO ANTHONY
ENDRA Life Sciences | 4: Statement of changes in beneficial ownership of securities-Director Tokman Alexander Y
ENDRA Life Sciences | 4: Statement of changes in beneficial ownership of securities-Chief Technology Officer Thornton Michael Milos
ENDRA Life Sciences | 4: Statement of changes in beneficial ownership of securities-Director DIGIANDOMENICO ANTHONY
ENDRA Life Sciences | SC 13G: Statement of acquisition of beneficial ownership by individuals-Michael Bryan, Sr.(6.1%)
ENDRA Life Sciences | 4: Statement of changes in beneficial ownership of securities
ENDRA Life Sciences | 4: Statement of changes in beneficial ownership of securities
ENDRA Life Sciences | 4: Statement of changes in beneficial ownership of securities
ENDRA Life Sciences | 4: Statement of changes in beneficial ownership of securities
ENDRA Life Sciences | 4: Statement of changes in beneficial ownership of securities
ENDRA Life Sciences | 4: Statement of changes in beneficial ownership of securities
ENDRA Life Sciences | 4: Statement of changes in beneficial ownership of securities
ENDRA Life Sciences | 4: Statement of changes in beneficial ownership of securities
Analysis
Price Target
No Data
